DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.

DISCO Pharmaceuticals GmbH

Meet us at the DISCO!

The DISCO Pharmaceuticals GmbH website that is. Meet the team and read more about what we do and how we will transform the landscape of cancer care.

www.discopharma.de

Keep up to date with what's happening at DISCO by following us at DISCO Pharmaceuticals GmbH on LinkedIn and @DISCOPharma on #X

#surfaceome #proteomics #optoproteomics #drugdiscovery #biotech

Introducing DISCO Pharmaceuticals GmbH! The surfaceome company. 

Translating over a decade of research, DISCO launches today with its revolutionary surface proteomics platform to identify novel cancer targets on the cell surface at scale, and to develop first in class drugs. 

DISCO's mission is to improve treatment options for patients living with cancer by unleashing the full potential of targeted cancer therapies.  

Find out more: https://bit.ly/48qI8Fz

#surfaceome #proteomics #optoproteomics #drugdiscovery #biotech

Mobile Non Scaleable Content

CrUX Dataset

CrUX Top 50m

Project Leader

Deniz Bartsch

Research Associate

Heidi Funke

Chief Operating Officer (COO) and Founder

Johannes Heuckmann

Therese Liechtenstein

Christian R Schubert

Maina Bhaman

European Union (EU) Companies With More Than 10 Employees (Top 10K)

Europe, Middle East, and Africa (EMEA) Seed Stage Companies With Fewer Than 50 Employees (Top 10K)

Europe Companies (Top 10K)

Germany Startups

DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.

Sofinnova Partners

Seed Round - DISCO Pharmaceuticals

Cologne

Nordrhein-Westfalen

Germany

Europe

DISCO Pharmaceuticals

DISCO Pharmaceuticals GmbH on LinkedIn: #bioequityeurope2024 #proteomics #surfaceome #smallcelllungcancer ...

Manuela Lemmens on LinkedIn: Great !

DISCO dances out of the shadows with €20m for 'surfaceome'

Surfaceome company DISCO Pharmaceuticals launches with seed financing

AbbVie-backed Disco gets down with €20M to find new targets for antibody-based therapies

Disco Pharmaceuticals Raises €20M in Seed Financing

AbbVie-Backed Disco Launches with $20M in Funding, Targets Oncology

Roman Thomas on LinkedIn: Super-excited to share that our new company, DISCO Pharmaceuticals, has… | 41 ...

A scalable drug discovery platform that maps the cell surface to identify proteins and associated protein communities, providing target candidates for mono- and bi-specific antibodies.

A pipeline program focused on developing proprietary antibody-based treatments for Small Cell Lung Cancer, leveraging the surfaceome mapping technology.

A pipeline program aimed at developing treatments for Microsatellite-Stable Colorectal Cancer, addressing a high unmet medical need with limited treatment options.

India

Asia

DISCO Pharmaceuticals is a biopharmaceutical company focused on redefining cancer drug discovery by developing novel cancer-selective cell surface targets for the creation of innovative therapeutics.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	f979d730
crunchbase profile	general	Nov 22, 2024 8:49 AM	07904bae
li profile	general	Feb 6, 2024 7:51 AM	bbb9c44d
translate crunchbase fundingrounds	general	Nov 22, 2024 11:00 AM	f152ad0d
peers	general	Feb 6, 2024 7:51 AM	736a80ae
news basic	general
bundesanzeiger	filings	Feb 12, 2024 3:21 PM	bc8d161f
financials download nd	financials
private financials	financials

DE:DISCOPHARMA

DISCO Pharmaceuticals